Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1996-03-01
1997-08-26
Richter, Johann
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
548414, 548415, A61K 3140, C07F 940
Patent
active
056611749
ABSTRACT:
Compounds of the tautomeric formula Ia, Ib or Ic, ##STR1## where R is a radical of the formula ##STR2## are effective compounds for the treatment and prophylaxis of degenerative bone disorders. They are used as pharmaceuticals.
REFERENCES:
patent: 4255572 (1981-03-01), Kruger et al.
patent: 4927814 (1990-05-01), Gall et al.
patent: 4942157 (1990-07-01), Gall et al.
patent: 5294608 (1994-03-01), Lang et al.
patent: 5395826 (1995-03-01), Nauman et al.
"New Methods of Preparative Organic Chemistry IV, Synthesis Using Heterocyclic Amides (Azolides)", Staab, H.A., Angew. Chem. Internat. Edit. 1(7):351-367 (1962).
Advanced Organic Chemistry--Reactions, Mechanisms, and Structure March J., Fourth Edition, pp. 348-352. (1992).
"Zur Guanylierung von Aminen mit O-Methyl-Isoharnstoff-Sulfat", Weiss et al., Chemiker-Zeitung, 98(12):617-621 (1974).
Lang Hans-Jochen
Moura Anne-Marie
Naumann Christoph
Sandow Jurgen
Hoechst Aktiengesellschaft
Peabody John
Richter Johann
LandOfFree
Guanidinealkyl-1,1-bisphosphonic acid derivatives, process for t does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Guanidinealkyl-1,1-bisphosphonic acid derivatives, process for t, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Guanidinealkyl-1,1-bisphosphonic acid derivatives, process for t will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1988852